Amlodipine Plus Botulinum Toxin for Focal Dystonia

Status Completed

Clinical Trial Summary

Objective: To determine if the calcium channel blockers, amlodipine can augment the effect of botulinum toxin injections in the treatment of focal dystonia.

Study Population: 20 patients with cervical dystonia

Design: Double-bind, placebo-controlled clinical trail.

Outcome measures: For patients: dystonia rating scales (Twistrs, Fahn-Marsden dystonia scale, NINDS subjective patient rating scale), and hand grip strength. For healthy volunteers: Amplitude of EDB MEP.

Clinical Trial Description

Objective: To determine if the calcium channel blocker, amlodipine can augment the effect of botulinum toxin injections in the treatment of focal dystonia.

Study Population: 20 patients with cervical dystonia

Design: Double-bind, placebo-controlled clinical trail.

Outcome measures: dystonia rating scales (TWISTRS) ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00015457
Study type	Interventional
Source	National Institutes of Health Clinical Center (CC)
Contact
Status	Completed
Phase	Phase 2
Start date	April 2001

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04692285` - Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia	Phase 1
Completed	`NCT00505323` - Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Palliadal Lesion : Evaluation of Safety and Effectiveness	Phase 1
Terminated	`NCT03206112` - Loss of Depotentiation in Focal Dystonia
Completed	`NCT00025701` - EEG and EMG Studies of Hand Dystonia	N/A
Completed	`NCT02334683` - Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia	N/A
Completed	`NCT03797638` - Characterization of Manual Dexterity by Finger Force Manipuladum (FFM) in Patients With Writer's Cramp and in Control Subjects	N/A
Terminated	`NCT01750346` - Acetyl Hexapeptide-8 for Blepharospasm	Phase 2
Completed	`NCT01738581` - rTMS and Retraining in Focal Hand Dystonia	Phase 1/Phase 2
Terminated	`NCT02106936` - Depotentiation in People With Focal Hand Dystonia	N/A
Completed	`NCT00310414` - fMRI Studies of Task Specificity in Focal Hand Dystonia	N/A
Completed	`NCT00309010` - Neurophysiology of Task-Specificity of Focal Hand Dystonia	N/A
Completed	`NCT03471923` - Non-Motor Features of Cervical Dystonia (CD)
Completed	`NCT00306865` - Brain Changes in Patients With Focal Hand Dystonia	N/A
Completed	`NCT00411255` - Brain Stimulation to Treat Blepharospasm or Meige Syndrome	Phase 2
Terminated	`NCT00487383` - Brain Changes in Blepharospasm
Recruiting	`NCT05095740` - Effects of Neuromodulation in Laryngeal Dystonia	N/A
Completed	`NCT00713414` - Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
Completed	`NCT00942851` - A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm	Phase 1/Phase 2
Completed	`NCT00118586` - Neuropathology of Spasmodic Dysphonia
Completed	`NCT02326818` - Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity	Phase 3